{"doi":"10.1177/21501319251360113","title":"Group-Based Integrative Pain Management: Feasibility of a Factorial Randomized Trial in Safety-Net Primary Care","abstract":"Purpose: This pilot study tested the feasibility and acceptability of a pragmatic randomized trial evaluating group-based non-pharmacologic approaches to increase access in primary care and improve pain-related outcomes. Methods: This 2 × 2 factorial trial assessed two 12-week interventions: group acupuncture and integrative group medical visits (IGMVs). Adults with chronic pain lasting ≥3 months were enrolled from safety-net primary care clinics. Participants were randomized to group acupuncture, IGMVs, both, or neither (usual care). We analyzed data using linear mixed models, ANCOVA, and abductive qualitative analysis. Results: Overall, 44 participants were randomized (25 English-speaking and 19 Spanish-speaking); 59% were female (mean age = 55 years), 21% African American or Black, 52% Latine, 21% non-Latine White, and 5% more than 1 race; and 78% had annual income <$25 000. At baseline, the average duration of chronic pain was 13.0 years, and the mean pain impact score was 36.0 (SD = 6.4). Participants randomized to interventions attended 6 of 12 sessions on average; 89% would participate again; and 86% reported clinically relevant pain improvements versus 20% in usual care ( P < .001). Qualitative data revealed substantial barriers to accessing multimodal care and social benefits of group-based models. Conclusion: Group-based integrative pain management is feasible and acceptable when co-located within safety-net primary care. Clinicaltrials.gov Registration Number : NCT05906784 ( http://clinicaltrials.gov/study/NCT05906784 ).","journal":"Journal of Primary Care & Community Health","year":2025,"id":528674,"datarank":0.16479184330021646,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.0,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":2,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.959,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT05906784"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1282149,"name":"Jesse Wennik","orcid":null,"position":1,"is_corresponding":false},{"id":1282147,"name":"Pamela Swedlow","orcid":null,"position":2,"is_corresponding":false},{"id":1406985,"name":"Julia M. Wu","orcid":"0000-0002-0042-2938","position":3,"is_corresponding":false},{"id":453130,"name":"Wendy Hartogensis","orcid":"0000-0002-4979-8661","position":4,"is_corresponding":false},{"id":1406986,"name":"Jo Jackson","orcid":"0000-0001-5308-4509","position":5,"is_corresponding":false},{"id":355824,"name":"Maria T. Chao","orcid":"0000-0001-9846-7044","position":6,"is_corresponding":false},{"id":389908,"name":"Ariana Thompson‐Lastad","orcid":"0000-0002-4880-1371","position":0,"is_corresponding":true}],"reference_count":51,"raw_metadata":null,"created_at":"2026-07-19T02:50:52.565868Z","pmid":"40817732","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}